High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy. - Parissenti, Amadeo M.; Pritzker, Laura B.; Dahle, Maria Aanesland; Gythfeldt, Hedda von der Lippe; Masilamani, Twinkle; Theriault, Gabriel; St-Onge, Renée; D'costa, Lavina; Lingjaerde, Ole Christian; Haugen, Mads Haugland; Engebraaten, Olav (Breast Cancer Research, 2025)